Latham & Watkins Advises Underwriters to TRACON Pharmaceuticals' Initial Public Offering

The company offers 3,600,000 shares of common stock at a price to the public of $10.00 per share.

February 5, 2015

TRACON Pharmaceuticals, Inc. has announced the pricing of its initial public offering of 3,600,000 shares of common stock at a price to the public of $10.00 per share. TRACON’s common stock began trading on The NASDAQ Global Market under the symbol “TCON” on January 30, 2015. The offering closed on February 4, 2015, subject to customary closing conditions. Latham & Watkins LLP represents the underwriters in the offering, with a corporate team led by partners Cheston Larson and Matthew Bush, with associates Christopher Geissinger and David Greer in San Diego.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.